Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Asian Pacific Journal of Tropical Biomedicine ; (12): 992-998, 2012.
Article in English | WPRIM | ID: wpr-312452

ABSTRACT

<p><b>OBJECTIVE</b>To study the derivatives of 1,2,4-triazino[5,6-b]indole-3-thione for antidepressant activity in olfactory bulbectomized (OBX) rats. Out of various derivatives tested for acute tail suspension test, the two derivatives showing prominent action were selected for bilateral olfactory bulbectomy model of chronic depression in rats.</p><p><b>METHODS</b>The sub acute effects of 14-day oral pretreatment of two derivatives labeled as 3a (70 mg/kg) and 3r (70 mg/kg), imipramine (20 mg/kg), fluoxetine (30 mg/kg) and moclobemide (15 mg/kg) were evaluated on bilateral bulbectomy induced rise in body weight, hyperphagia, hyperactivity, and on sexual dysfunction. The serum sodium concentration, body temperature, and heart rate were also recorded.</p><p><b>RESULTS</b>The derivatives 3a and 3r showed reversal of drop in body weight, reversed OBX induced hyperactivity, normalized body temperature, heart rate, and serum sodium concentration. In elevated maze test, moclobemide, 3a, 3r treatment significantly reduced time spent in open arm as compared to OBX rats. 3a and 3r also improved sexual behavior parameters.</p><p><b>CONCLUSIONS</b>The present study shows promising antidepressant action and provides a proof of concept for the chronic treatment of 3a, 3r to treat depression.</p>


Subject(s)
Animals , Female , Male , Rats , Acetamides , Pharmacology , Acetanilides , Pharmacology , Antidepressive Agents , Pharmacology , Behavior, Animal , Depression , Drug Therapy , Disease Models, Animal , Dose-Response Relationship, Drug , Fluoxetine , Pharmacology , Imipramine , Pharmacology , Moclobemide , Pharmacology , Olfaction Disorders , Pathology , Olfactory Bulb , General Surgery , Rats, Sprague-Dawley , Triazines , Pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL